Omeros Corporation
15 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
11
Ending by 2030
Nov 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 21 to 30, 2026 · next Nov 21
- 2 fees due Feb 11, 2027
- 1 fee due Mar 1, 2027The maintenance fee for Use of PDE7 Inhibitors for the Treatment of Movement Disorders (US 9,119,822) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
- 1 fee due May 7, 2027The maintenance fee for MASP-2 Inhibitors and Methods of Use (US 11,807,641) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors (US 9,220,715) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation (US 11,884,742) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 1 fee due Aug 13, 2027The maintenance fee for Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant (US 11,896,621) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
- 1 fee due Oct 2, 2027The maintenance fee for Chimeric Inhibitor Molecules of Complement Activation (US 11,945,848) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
- 2 fees due Nov 14, 2027
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,786,139 | PDE10 Inhibitors and Related Compositions and Methods In force · Medium confidence | In force | Medium confidence | |
| US 8,278,327 | PDE10 Inhibitors and Related Compositions and Methods In force · Medium confidence | In force | Medium confidence | |
| US 11,884,742 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation In force · High confidence | In force | High confidence | |
| US 9,119,822 | Use of PDE7 Inhibitors for the Treatment of Movement Disorders In force · Medium confidence | In force | Medium confidence | |
| US 10,064,850 | Compositions and Methods for Prophylaxis and Treatment of Addictions In force · Medium confidence | In force | Medium confidence | |
| US 11,241,420 | Compositions and Methods for Prophylaxis and Treatment of Addictions In force · Medium confidence | In force | Medium confidence | |
| US 8,637,528 | Use of PDE7 Inhibitors for the Treatment of Movement Disorders In force · Medium confidence | In force | Medium confidence | |
| US 8,790,696 | Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures In force · Medium confidence | In force | Medium confidence | |
| US 9,783,521 | PDE10 Inhibitors and Related Compositions and Methods In force · High confidence | In force | High confidence | |
| US 11,203,622 | Masp Isoforms as Inhibitors of Complement Activation In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 64: 15 patents in force now held by others · 2 lapsed for an unpaid fee · 38 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
29 pending · 45 abandoned · 73 no status recorded